A Study to check if adding an Ayurvedic medicine to regular treatment helps in Men with Enlarged Prostate

A Randomized Controlled Trial to Evaluate the Add on Effect of Dhanyaka Gokshura Ghrita with Silodosin and Dutasteride in the Management of Mutraghata with special reference to Benign Prostatic Hyperplasia - NIL

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/04/107511

Enrollment

Registered

2026-04-02

Start date

Unknown

Completion date

Unknown

Last updated

2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N401- Benign prostatic hyperplasia withlower urinary tract symptoms

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients diagnosed with Mutraghata as per classical Ayurvedic and modern diagnostic parameters. Diagnosed cases of BPH, without acute retention of urine All grades of BPH without acute retention of urine Patients willing to participate and provide informed written consent.

Exclusion criteria

Exclusion criteria: Patients with structural abnormalities of the urinary tract requiring surgical intervention. Known cases of chronic kidney disease, prostate cancer, or neurogenic bladder. Patients on long-term catheterization. Severe systemic illness or comorbidities interfering with the study. Known hypersensitivity to any ingredients of Dhanyaka Gokshura Ghrita.

Design outcomes

Primary

Measure	Time frame
Improvement in voiding dysfunction, measured by changes in IPSS (urinary frequency, urgency, intermittency etc.), USG (PVRU, Bladder wall thickness) and Uroflometry (flow rate and voiding time)Timepoint: 30 days	—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactProf Rahul Sherkhane

IMS BHU

rahulsherkhane@bhu.ac.in8233829723

Outcome results